India prostate cancer market is forecast to grow at a CAGR of around 9% during the forecast period. The incidence of prostate cancer is less as compared to the western economies as prostate cancer is among the top 3 cancer in men in western economies whereas it is at 16th rank in the incidence cancer cases in the country in 2018. As per the World Health Organization, the estimated new cases in 2018 were 26,000- and 5-year prevalence is around 47,500. In India, the registered cases of prostate cancer are more in big cities such as Bangalore, Mumbai, Pune, Kolkata, Delhi, and Thiruvananthapuram. The data for prostate cancer incidences in India is only indicative as there are no PSA testing norms in India at a mass scale which may result in many prostate cancer cases going unreported. In India, data regarding the true incidence of prostate cancer is limited mainly due to the fact that this entity is not a notifiable disease and there are only a handful of population-based cancer registries in India. 

Moreover, the country’s age composition is that more than 50% of the population is below 25 years of age making it less demanding for prostate cancer services. This is due to the fact that the chances of having prostate cancer in men increase with increasing age. India has a population of 1.3 billion in 2020 and in 2020, the average age of an Indian is around 29 years compared to 37 years for a Chinese and 48 years for a Japanese. This makes it a less demanding market for prostate cancer services and diagnosis. However, the market will show impressive growth due to increasing medical tourism in the country. This is primarily due to cheaper healthcare services as compared to western economies.

The companies which are contributing significantly in the market include Abbott Laboratories, Amgen Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Co., Endo Pharmaceuticals Inc., Ferring Pharmaceuticals Inc., GlaxoSmithKline PLC, Johnson & Johnson, Pfizer Inc., Siemens Healthcare AG, and others. The market players are considerably contributing to the market growth by the adoption of various growth strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.

Research Methodology

The market study is incorporated by extensive primary and secondary research conducted by the research team.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. In the report, the analysis of the country is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts to brings authenticity to the reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for drug manufacturing companies, medical device manufacturing companies, contract manufacturers, government organizations, and venture capitalists for the comprehensive market analysis. The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. India Prostate Cancer Market Research and Analysis by Diagnostic Technique
2. India Prostate Cancer Market Research and Analysis by Therapy

The Report Covers

• Comprehensive research methodology of India Prostate Cancer Market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting India Prostate Cancer Market.
• Insights about market determinants which are stimulating India Prostate Cancer Market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.